|
| Exchange Disseminated Time 07/11/2016 18:16:22 | Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on November 10, 2016, inter alia, to consider and approve the following:
1. Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter/half yearly ending September 30, 2016;
2. Declaration of Interim Dividend on quarterly basis & approval of 1st Interim Dividend for the year 2016-17.
In view of the above, the trading window for dealing in the securities of the Company is closed for the Specified Persons (Directors & Designated Employees) from November 04, 2016 to November 13, 2016 (both days inclusive) as per Company's Code of Conduct to regulate, monitor and report trading by insiders pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. |
|
|